Sun Pharma gets US FDA nod for migraine treatment injection
A subsidiary of Sun Pharmaceutical Industries has received approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of Sumatriptan Succinate Injection.
June 22, 2011 / 13:03 IST
Moneycontrol Bureau
A subsidiary of Sun Pharmaceutical Industries has received approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of Sumatriptan Succinate injection. The medicine is indicated for the acute treatment of migraine attacks and cluster headache episodes. Sun
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
